We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » AstraZeneca’s Triple-Combo Therapy Helps COPD Patients, Study Finds
AstraZeneca’s Triple-Combo Therapy Helps COPD Patients, Study Finds
AstraZeneca released full results from a phase 3 trial of its triple combination inhaled therapy Breztri Aerosphere in moderate to severe chronic obstructive pulmonary disease (COPD) patients, finding that it significantly reduced the rate of flare ups compared to two other combination treatments.